| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 51.266 | 40.778 | 11.457 | 11.212 | 6.866 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 51.266 | 40.779 | 11.457 | 11.212 | 6.866 | 0 | 0 | 10 | 0 | 0 |
| Total Expenses - EUR | 44.507 | 36.119 | 16.225 | 14.924 | 14.244 | 12 | -23 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | 6.759 | 4.660 | -4.768 | -3.711 | -7.378 | -12 | 23 | 10 | 0 | 0 |
| Net Profit/Loss - EUR | 5.221 | 4.183 | -5.036 | -3.824 | -7.446 | -12 | 23 | 10 | 0 | 0 |
| Employees | 8 | 4 | 4 | 4 | 3 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Nova Bioquest Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 15.533 | 12.255 | 8.981 | 5.805 | 2.741 | 2.689 | 2.629 | 2.637 | 2.629 | 2.614 |
| Current Assets | 7.721 | 475 | 320 | 533 | 68 | 224 | 0 | 10 | 10 | 10 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2.336 | 35 | 34 | 34 | 33 | 32 | 0 | 0 | 0 | 0 |
| Cash | 5.385 | 440 | 285 | 499 | 35 | 192 | 0 | 10 | 10 | 10 |
| Shareholders Funds | -32.665 | -28.149 | -32.709 | -35.932 | -42.683 | -41.885 | -40.933 | -41.050 | -40.926 | -40.697 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 55.919 | 40.879 | 42.009 | 42.270 | 45.492 | 44.798 | 43.562 | 43.697 | 43.565 | 43.321 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Nova Bioquest Srl